MANASSAS, Va., Sept. 27 /PRNewswire/ -- Mediatech, Inc. is settling into their brand new 100,000-ft2 facility constructed on 10 acres of land in Prince William County. Right down the road from George Mason University's National Center for Biodefense, Mediatech joins other biotechnology and technology companies, including ATCC in Innovation Park.
The brand new manufacturing plant has been a work in progress since 2004 when Mediatech was named VaBio Company of the Year. The state and county announced they would provide cash grants and other incentives for the relocation 17 miles west. Mediatech's new corporate headquarters and manufacturing operations facility integrates state-of-the-art systems and innovative technology.
Emphasis is on the unique filling process, designed by in house personnel, that provides higher sterility assurance levels than all others in the industry. In addition to these vast improvements, the manufacturing plant will also have separate production lines for animal and non-animal products, a major benefit for pharmaceutical customers.
Mediatech, Inc was recently licensed as a drug establishment for the production of Water for Injection (WFI). All products are made using WFI quality water that is tested in accordance with the U.S. Pharmacopeia. The WFI system in place is capable of producing up to 28,000 liters of WFI per day.
Although all contact telephone lines will remain the same, please be advised the new Mediatech, Inc. address is:
9345 Discovery Blvd.
Manassas, VA 20109
About Mediatech, Inc
Mediatech, Inc. is a leading manufacturer and supplier of cell culture and molecular biology reagents to biopharmaceutical, academic and government research facilities, as well as biotechnology companies. In addition to following current Good Manufacturing Processes (cGMP) and complying with FDA Guidelines for Class I Medical Devices, Mediatech is certified under ISO 13485:2003 and compliant with ISO 17025:2001. Mediatech's facility design and Quality Assurance Systems guarantee low endotoxin levels for both liquid and powdered products and meets the most rigid Sterility Assurance Levels for liquid products. All cellgro(R) basal media and salt solutions must test negative for mycoplasma prior to release. For more information visit http://www.cellgro.com.
Contact: Julie Fry, International Marketing Associate I, Mediatech, Inc. 1.800.CELLGRO or email@example.com.
|SOURCE Mediatech, Inc.|
Copyright©2007 PR Newswire.
All rights reserved